Quentin has more than 13 years of experience in Private Equity within the healthcare space with more than 10 Growth/Buyout investments performed in that domain since 2011.
His career started within Mérieux Equity Partners in 2011 as Analyst. Previously, he interned at Rothschild Martin Maurel as a financial analyst.
Quentin is now Director and actively works on the sourcing, evaluation, and monitoring of Mérieux Equity Partners’ investments. He is based in Paris and is currently board member of Biobest, GTP Bioways, Theravia and Piercan, and observer of Serb.
Quentin has a Master degree in Finance and Management from the Reims Business School and a European Business Management License from the University of Coventry (England).